AN2 Therapeutics, Inc. (ANTX)

Profile

https://www.an2therapeutics.com

AN2 Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing novel small-molecule therapeutics derived from its boron chemistry platform. The company’s current pipeline includes programs in infectious diseases, hematologic disorders, and oncology, with research efforts aimed at addressing serious and rare conditions with high unmet medical needs. Its product candidates include oral therapies under development for diseases such as Chagas disease, non-tuberculous mycobacterial lung disease, and other infectious disease targets, alongside earlier-stage oncology and global health programs. AN2 Therapeutics operates as a drug discovery and development business, advancing its candidates through preclinical and clinical studies to support potential future therapies for patients and healthcare providers.